• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙化及主动脉瓣狭窄严重程度中的瓣膜破骨细胞

Valvular osteoclasts in calcification and aortic valve stenosis severity.

作者信息

Nagy Edit, Eriksson Per, Yousry Mohamed, Caidahl Kenneth, Ingelsson Erik, Hansson Göran K, Franco-Cereceda Anders, Bäck Magnus

机构信息

Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Int J Cardiol. 2013 Oct 3;168(3):2264-71. doi: 10.1016/j.ijcard.2013.01.207. Epub 2013 Feb 27.

DOI:10.1016/j.ijcard.2013.01.207
PMID:23452891
Abstract

BACKGROUND

Bone remodeling in calcified aortic valves is thought to originate from microfractures at multiple sites of the valve, at which osteoclasts and osteoblasts are recruited. The aim of the present study was to assess circulating mediators of bone homeostasis, correlate them to the severity of stenosis and explore the spatio-temporal distribution of bone turnover in different parts of calcified aortic valve tissue.

METHODS AND RESULTS

Plasma and explanted aortic valves were obtained from 46 patients undergoing aortic valve replacement surgery. Plasma levels of tartrate-resistant acid phosphatase (TRAP), receptor activator of nuclear-κB (RANK) ligand and Runt-related transcription factor 2 (Runx2/Cbfa1) exhibited a significant correlation to the severity of aortic stenosis. mRNA levels in normal, thickened and calcified parts of aortic valves assessed by quantitative real-time PCR were significantly elevated in calcified parts of valves for TRAP (5.08 ± 1.6-fold, P<0.001) RANK ligand (8.6 ± 4.2-fold, P<0.001) and RANK (1.98 ± 0.78-fold, P=0.015). In an age, gender and aortic valve anatomy-adjusted multivariable regression analysis the local transcript levels of TRAP correlated significantly with echocardiographic parameters quantifying stenosis severity in early stages, whereas the expression level of Runx2/Cbfa1 was a predictor of the stenosis severity in advanced stages.

CONCLUSIONS

These findings suggest a critical role of bone turnover as a determinant of aortic stenosis severity.

摘要

背景

钙化主动脉瓣中的骨重塑被认为起源于瓣膜多个部位的微骨折,破骨细胞和成骨细胞在这些部位被募集。本研究的目的是评估骨稳态的循环介质,将它们与狭窄严重程度相关联,并探索钙化主动脉瓣组织不同部位骨转换的时空分布。

方法与结果

从46例行主动脉瓣置换手术的患者中获取血浆和离体主动脉瓣。抗酒石酸酸性磷酸酶(TRAP)、核因子κB受体活化因子(RANK)配体和Runx2/Cbfa1的血浆水平与主动脉狭窄的严重程度呈显著相关。通过定量实时PCR评估的主动脉瓣正常、增厚和钙化部分的mRNA水平,在瓣膜钙化部分中,TRAP(5.08±1.6倍,P<0.001)、RANK配体(8.6±4.2倍,P<0.001)和RANK(1.98±0.78倍,P=0.015)显著升高。在年龄、性别和主动脉瓣解剖结构调整后的多变量回归分析中,TRAP的局部转录水平与早期量化狭窄严重程度的超声心动图参数显著相关,而Runx2/Cbfa1的表达水平是晚期狭窄严重程度的预测指标。

结论

这些发现表明骨转换作为主动脉狭窄严重程度的决定因素起着关键作用。

相似文献

1
Valvular osteoclasts in calcification and aortic valve stenosis severity.钙化及主动脉瓣狭窄严重程度中的瓣膜破骨细胞
Int J Cardiol. 2013 Oct 3;168(3):2264-71. doi: 10.1016/j.ijcard.2013.01.207. Epub 2013 Feb 27.
2
Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.激活的组织重塑能否被视为瓣膜进行性退变的早期标志物?天然退变主动脉瓣及生物瓣置换术后检查点和细胞外基质重塑基因表达的比较分析。
Amino Acids. 2007 Jan;32(1):109-14. doi: 10.1007/s00726-006-0376-0. Epub 2006 Aug 2.
3
Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves.破骨细胞与骨保护素对主动脉瓣钙化退变方式的影响。
Pol Arch Med Wewn. 2016;126(3):149-58. doi: 10.20452/pamw.3326. Epub 2016 Mar 22.
4
Interferon-γ Released by Activated CD8 T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves.活化的CD8 T淋巴细胞释放的干扰素-γ损害钙化人主动脉瓣中破骨细胞的钙吸收潜能。
Am J Pathol. 2017 Jun;187(6):1413-1425. doi: 10.1016/j.ajpath.2017.02.012. Epub 2017 Apr 19.
5
Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study.硬化素作为主动脉瓣钙化潜在的新型生物标志物:一项体内和体外研究。
J Heart Valve Dis. 2013 May;22(3):317-25.
6
Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves.人纤维性和狭窄性主动脉瓣中血栓调节蛋白-2 的增加。
Atherosclerosis. 2012 Jan;220(1):66-71. doi: 10.1016/j.atherosclerosis.2011.10.003. Epub 2011 Oct 12.
7
Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related transcription factor 2.Twist相关蛋白1通过直接抑制 runt相关转录因子2负向调控人主动脉瓣间质细胞的成骨细胞转分化。
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1700-1708.e1. doi: 10.1016/j.jtcvs.2014.02.084. Epub 2014 Mar 4.
8
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.核因子κB受体激活剂配体和骨保护素调节主动脉瓣钙化。
J Mol Cell Cardiol. 2004 Jan;36(1):57-66. doi: 10.1016/j.yjmcc.2003.09.015.
9
Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.重度主动脉瓣狭窄患者主动脉瓣组织中骨保护素的值取决于是否合并冠状动脉疾病。
Cardiovasc Pathol. 2016 May-Jun;25(3):181-184. doi: 10.1016/j.carpath.2015.12.003. Epub 2015 Dec 30.
10
[Histopathologic features of degenerative aortic valve and its mechanisms].[退行性主动脉瓣的组织病理学特征及其机制]
Zhonghua Yi Xue Za Zhi. 2013 Jan 22;93(4):280-4.

引用本文的文献

1
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies.慢性肾脏病中的瓣膜钙化:近期临床和临床前研究的新见解
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i27-i45. doi: 10.1093/ckj/sfae421. eCollection 2025 Mar.
2
Y chromosome-linked UTY modulates sex differences in valvular fibroblast methylation in response to nanoscale extracellular matrix cues.Y染色体连锁的UTY基因可调节瓣成纤维细胞甲基化中的性别差异,以响应纳米级细胞外基质信号。
Sci Adv. 2025 Mar 14;11(11):eads5717. doi: 10.1126/sciadv.ads5717. Epub 2025 Mar 12.
3
Single-cell transcriptomics reveals cellular heterogeneity and macrophage-to-mesenchymal transition in bicuspid calcific aortic valve disease.
单细胞转录组学揭示了二叶式钙化主动脉瓣疾病中的细胞异质性和巨噬细胞向间充质转化。
Biol Direct. 2023 Jun 30;18(1):35. doi: 10.1186/s13062-023-00390-w.
4
Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease.作为一种靶向钙化性主动脉瓣疾病的纳米治疗系统,将shRNA-Runx2靶向胶原蛋白IV的纳米载体。
Mater Today Bio. 2023 Mar 28;20:100620. doi: 10.1016/j.mtbio.2023.100620. eCollection 2023 Jun.
5
Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus.主动脉瓣狭窄:关于后天性发病机制及与糖尿病不祥组合的综述
Egypt Heart J. 2023 Apr 7;75(1):26. doi: 10.1186/s43044-023-00345-6.
6
Aortic Stenosis: New Insights in Diagnosis, Treatment, and Prevention.主动脉瓣狭窄:诊断、治疗及预防的新见解
Korean Circ J. 2022 Oct;52(10):721-736. doi: 10.4070/kcj.2022.0234.
7
Profiling Genome-Wide DNA Methylation Patterns in Human Aortic and Mitral Valves.人类主动脉瓣和二尖瓣全基因组DNA甲基化模式分析
Front Cardiovasc Med. 2022 Apr 6;9:840647. doi: 10.3389/fcvm.2022.840647. eCollection 2022.
8
Towards Personalized Therapy of Aortic Stenosis.迈向主动脉瓣狭窄的个性化治疗
J Pers Med. 2021 Dec 3;11(12):1292. doi: 10.3390/jpm11121292.
9
Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.糖尿病性主动脉瓣疾病:分子机制与新型治疗策略。
J Cell Mol Med. 2021 Oct;25(20):9483-9495. doi: 10.1111/jcmm.16937. Epub 2021 Sep 24.
10
Protective Effects of Fucoxanthin on Hydrogen Peroxide-Induced Calcification of Heart Valve Interstitial Cells.岩藻黄质对过氧化氢诱导的心脏瓣膜间质细胞钙化的保护作用。
Mar Drugs. 2021 May 26;19(6):307. doi: 10.3390/md19060307.